MedTrace Logo

Stage 1 Treatment Development With Homeless Mothers

NCT01193114 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-03-01

Study results available
· View outcomes & findings →

Summary

Aim 1. Identify specific targets and processes of intervention among homeless substance abusing mothers with children between the ages of 2 and 6 years from information collected in focus groups and assessment interviews. Translate that information for the refinement of the ecologically based treatment manual.

Aim 2. Test the efficacy of the treatment in a nonrandomized pilot study and revise the manual based upon those findings.

Aim 3. Test the efficacy of the experimental intervention compared to treatment as usual (TAU) in a randomized pilot, with the goal to improve maternal substance abuse problems, social stability, and mental health. It is expected that the experimental intervention will be associated with lower substance use and related problem behaviors than TAU.

Aim 4. Test whether intended change processes (mediators) associated with the intervention produce the desired change in mother's substance use, social stability, and mental health. It is expected that self-efficacy will mediate substance use outcomes.

Aim 5. Explore how length of homelessness, age and ethnicity of the mother predict treatment response (moderators).

Aim 6. Explore the impact of the experimental intervention (Ecologically-Based Therapy)on interpersonal stress and child's mental health.

Conditions

Interventions

BEHAVIORAL

Ecologically Based Treatment (EBT)

Substance abuse treatment (the Community Reinforcement Approach), case management and housing.

BEHAVIORAL

Treatment as Usual (TAU)

Treatment/intervention as normally provided by community service agencies that service substance abusing homeless families.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Ohio State University

    lead OTHER

Principal Investigators

  • Natasha Slesnick, Ph.D. · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01193114 on ClinicalTrials.gov